Moderna, Inc.
MRNA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $15,966,720 | $37,989,900 | $70,770,280 | $102,353,940 |
| - Cash | $1,927,000 | $2,907,000 | $3,205,000 | $6,848,000 |
| + Debt | $747,000 | $1,243,000 | $1,200,000 | $916,000 |
| Enterprise Value | $14,786,720 | $36,325,900 | $68,765,280 | $96,421,940 |
| Revenue | $3,199,000 | $6,848,000 | $18,875,000 | $17,736,000 |
| % Growth | -53.3% | -63.7% | 6.4% | – |
| Gross Profit | $1,735,000 | $2,155,000 | $13,459,000 | $15,119,000 |
| % Margin | 54.2% | 31.5% | 71.3% | 85.2% |
| EBITDA | -$3,394,000 | -$3,283,000 | $9,768,000 | $13,528,000 |
| % Margin | -106.1% | -47.9% | 51.8% | 76.3% |
| Net Income | -$3,561,000 | -$4,714,000 | $8,362,000 | $12,202,000 |
| % Margin | -111.3% | -68.8% | 44.3% | 68.8% |
| EPS Diluted | -9.27 | -12.34 | 20.1 | 28.29 |
| % Growth | 24.9% | -161.4% | -29% | – |
| Operating Cash Flow | -$3,004,000 | -$3,118,000 | $4,981,000 | $13,620,000 |
| Capital Expenditures | -$1,051,000 | -$707,000 | -$400,000 | -$284,000 |
| Free Cash Flow | -$4,055,000 | -$3,825,000 | $4,581,000 | $13,336,000 |